New data from Moderna Inc's large COVID-19 vaccine trial shows that the protection it offers wanes over time, supporting the case for booster doses, the company said in a news release on Wednesday.
CHICAGO, Sept 16 ― New data from Moderna Inc's large Covid-19 vaccine trial shows that the protection it offers wanes over time, supporting the case for booster doses, the company said in a news release yesterday. “This is only one estimate, but we do believe this means as you look toward the.
New data from Moderna Inc's large COVID-19 vaccine trial shows that the protection it offers declines over time, supporting the case for booster doses, the company said in a news release on Wednesday.
Moderna on Wednesday posted a study suggesting immunity from its COVID-19 vaccine may wane over time, saying that a booster shot is necessary to maintain strong protection against variants of concern.